November 29, 2024 Holiday Shopping Sets New Records With $6.1B Spent Online
November 25, 2024 Bitcoin Nears $100K: Crypto Revolution Reshapes Wall Street
November 18, 2024 Biden’s Missile Strategy: Escalation Or Path To Peace?
November 10, 2024 Wall Street Soars: Trump’s Victory Ignites Market Surge
Apple: Why The Future Looks Far Less Secure
Amazon: Still A Buy Thanks To Bedrock And Trainium
Amazon: Not A Second-Tier AI Player Anymore, But I Need Better Numbers
The Market Is Wrong About Microsoft – Here’s Why
December 9, 2024 When to Switch Payroll Solutions and How to Make a Smooth Transition
November 24, 2024 Latest Finance Management Regulations in Australia
November 24, 2024 Finance Management Education Resources
November 18, 2024 Best Backtesting Software For Traders
November 18, 2024 Best Forex Trading Tools
Affimed N.V. (AFMD) Stock Forecast for 2024, 2025, 2026. Sell or Buy?
Updated: December 11, 2024 (03:04)
Sector: HealthcareThe share price of Affimed N.V. (AFMD) now
News Impact Analyzer
Full report
This Week
|
Bullish | Impact: 5 | News: 1 (1/0/0) |
Previous Week
|
Na | Impact: Na | News: Na |
Two Weeks Ago
|
Na | Impact: Na | News: Na |
Three Weeks Ago
|
Bearish | Impact: 5 | News: 2 |
Analyzing the Most Important AFMD news
Affimed's Lymphoma Breakthrough: Promising Phase 2 Results
Affimed Reports Steep Revenue Decline: Q3 EPS Dips to -€0.94
Affimed Prepares for Potentially Challenging Q3 Earnings Release
Historical and forecast chart of Affimed N.V. stock
The chart below shows the historical price of Affimed N.V. stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Affimed N.V. stock price can be found in the table below.
Long-term forecasts by years.
Comprehensive Analysis of Affimed N.V. (AFMD) Stock Market Performance
Our multifaceted analysis of Affimed N.V.'s stock market is grounded in the company's key news stories, insights from reputable analysts, as well as mathematical and technical evaluations. Taking into account assessments from each of these aspects in real-time helps us address the most crucial questions for investors in the most objective way possible:
- When should I take profit in Affimed N.V. stock?
- When should I record a loss on Affimed N.V. stock?
- What are analysts' forecasts for Affimed N.V. stock?
- What is the future of Affimed N.V. stock?
We forecast Affimed N.V. stock performance using neural networks based on historical data on Affimed N.V. stocks.
Affimed N.V. News influencing stock rates
As of now, Panda has combed through 3 news items directly related to AFMD from the last 30 days. Out of these, 1 clearly showcase a bullish trend, while 2 display bearish tendencies, and 0 events are neutral.
The strength of the bearish trend is dominating bullish sentiments by 1.78 times, indicating that the current news landscape is negatively impacting the company's stock prices in the foreseeable future.
The news analyzed fell within the period from Nov 13, 2024, to Dec 09, 2024.
Affimed Plans $20M Mixed Securities Issuance
Affimed N.V., a clinical-stage biopharmaceutical company, is engaged in the discovery and development of immunotherapy treatments for cancer in the United States, Europe and Germany. The lead product candidate is AFM13, which has completed a Phase II clinical trial for CD30-positive T-cell lymphoma and Hodgkin’s lymphoma (HL) and is in Phase II clinical trials for peripheral T-cell lymphoma and transformed fungal mycosis.
Affimed N.V. daily forecast for a month
Date | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Dec 13 | 2.28 | 2.24 | 2.31 | 3.01 |
Dec 14 | 2.27 | 2.22 | 2.29 | 3.23 |
Dec 15 | 2.22 | 2.17 | 2.28 | 5.03 |
Dec 16 | 2.21 | 2.15 | 2.24 | 3.87 |
Dec 17 | 2.23 | 2.20 | 2.29 | 3.81 |
Dec 18 | 2.26 | 2.21 | 2.32 | 5.11 |
Dec 19 | 2.29 | 2.22 | 2.31 | 4.00 |
Dec 20 | 2.26 | 2.21 | 2.29 | 3.38 |
Dec 21 | 2.18 | 2.11 | 2.22 | 5.11 |
Dec 22 | 2.18 | 2.14 | 2.22 | 3.83 |
Dec 23 | 2.18 | 2.13 | 2.25 | 5.91 |
Dec 24 | 2.26 | 2.19 | 2.32 | 5.98 |
Dec 25 | 2.33 | 2.26 | 2.38 | 5.15 |
Dec 26 | 2.34 | 2.32 | 2.39 | 3.11 |
Dec 27 | 2.38 | 2.34 | 2.45 | 4.43 |
Dec 28 | 2.40 | 2.35 | 2.45 | 4.34 |
Dec 29 | 2.42 | 2.37 | 2.48 | 4.57 |
Dec 30 | 2.39 | 2.35 | 2.45 | 4.18 |
Dec 31 | 2.31 | 2.28 | 2.33 | 2.02 |
Jan 01 | 2.25 | 2.20 | 2.30 | 4.54 |
Jan 02 | 2.22 | 2.16 | 2.27 | 5.00 |
Jan 03 | 2.23 | 2.18 | 2.29 | 5.07 |
Jan 04 | 2.30 | 2.27 | 2.34 | 3.12 |
Jan 05 | 2.30 | 2.26 | 2.34 | 3.42 |
Jan 06 | 2.30 | 2.27 | 2.32 | 2.23 |
Jan 07 | 2.30 | 2.25 | 2.35 | 4.12 |
Jan 08 | 2.29 | 2.22 | 2.35 | 5.91 |
Jan 09 | 2.23 | 2.17 | 2.26 | 3.98 |
Jan 10 | 2.24 | 2.20 | 2.28 | 3.42 |
Jan 11 | 2.22 | 2.18 | 2.25 | 3.35 |
Affimed N.V. Daily Price Targets
Affimed N.V. Stock Forecast 12-13-2024.
Forecast target price for 12-13-2024: $2.28.
Negative dynamics for Affimed N.V. shares will prevail with possible volatility of 2.924%.
Pessimistic target level: 2.24
Optimistic target level: 2.31
Affimed N.V. Stock Forecast 12-14-2024.
Forecast target price for 12-14-2024: $2.27.
Negative dynamics for Affimed N.V. shares will prevail with possible volatility of 3.131%.
Pessimistic target level: 2.22
Optimistic target level: 2.29
Affimed N.V. Stock Forecast 12-15-2024.
Forecast target price for 12-15-2024: $2.22.
Negative dynamics for Affimed N.V. shares will prevail with possible volatility of 4.786%.
Pessimistic target level: 2.17
Optimistic target level: 2.28
Affimed N.V. Stock Forecast 12-16-2024.
Forecast target price for 12-16-2024: $2.21.
Negative dynamics for Affimed N.V. shares will prevail with possible volatility of 3.724%.
Pessimistic target level: 2.15
Optimistic target level: 2.24
Affimed N.V. Stock Forecast 12-17-2024.
Forecast target price for 12-17-2024: $2.23.
Positive dynamics for Affimed N.V. shares will prevail with possible volatility of 3.667%.
Pessimistic target level: 2.20
Optimistic target level: 2.29
Affimed N.V. Stock Forecast 12-18-2024.
Forecast target price for 12-18-2024: $2.26.
Positive dynamics for Affimed N.V. shares will prevail with possible volatility of 4.866%.
Pessimistic target level: 2.21
Optimistic target level: 2.32
AFMD (AFMD) Monthly Stock Prediction for 2025
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jan. | 2.51 | 2.42 | 2.57 | 5.85 |
Feb. | 2.70 | 2.60 | 2.77 | 6.20 |
Mar. | 2.73 | 2.60 | 2.87 | 9.59 |
Apr. | 2.65 | 2.43 | 2.73 | 10.86 |
May. | 2.39 | 2.31 | 2.58 | 10.15 |
Jun. | 2.67 | 2.50 | 2.87 | 12.96 |
Jul. | 2.55 | 2.41 | 2.74 | 11.87 |
Aug. | 2.44 | 2.28 | 2.66 | 14.28 |
Sep. | 2.37 | 2.26 | 2.57 | 11.96 |
Oct. | 2.41 | 2.20 | 2.54 | 13.47 |
Nov. | 2.20 | 2.11 | 2.33 | 9.19 |
Dec. | 2.17 | 2.04 | 2.34 | 12.91 |
Affimed N.V. forecast for this year
Affimed N.V. Stock Prediction for Jan 2025
An uptrend is forecast for this month with an optimal target price of $2.50615. Pessimistic: $2.42. Optimistic: $2.57
Affimed N.V. Stock Prediction for Feb 2025
An uptrend is forecast for this month with an optimal target price of $2.70463. Pessimistic: $2.60. Optimistic: $2.77
Affimed N.V. Stock Prediction for Mar 2025
An uptrend is forecast for this month with an optimal target price of $2.73384. Pessimistic: $2.60. Optimistic: $2.87
Affimed N.V. Stock Prediction for Apr 2025
An downtrend is forecast for this month with an optimal target price of $2.65183. Pessimistic: $2.43. Optimistic: $2.73
Affimed N.V. Stock Prediction for May 2025
An downtrend is forecast for this month with an optimal target price of $2.39407. Pessimistic: $2.31. Optimistic: $2.58
Affimed N.V. Stock Prediction for Jun 2025
An uptrend is forecast for this month with an optimal target price of $2.67274. Pessimistic: $2.50. Optimistic: $2.87
Affimed N.V. Stock Prediction for Jul 2025
An downtrend is forecast for this month with an optimal target price of $2.55407. Pessimistic: $2.41. Optimistic: $2.74
Affimed N.V. Stock Prediction for Aug 2025
An downtrend is forecast for this month with an optimal target price of $2.43761. Pessimistic: $2.28. Optimistic: $2.66
Affimed N.V. Stock Prediction for Sep 2025
An downtrend is forecast for this month with an optimal target price of $2.37033. Pessimistic: $2.26. Optimistic: $2.57
Affimed N.V. Stock Prediction for Oct 2025
An uptrend is forecast for this month with an optimal target price of $2.41299. Pessimistic: $2.20. Optimistic: $2.54
Affimed N.V. Stock Prediction for Nov 2025
An downtrend is forecast for this month with an optimal target price of $2.19872. Pessimistic: $2.11. Optimistic: $2.33
Affimed N.V. Stock Prediction for Dec 2025
An downtrend is forecast for this month with an optimal target price of $2.1697. Pessimistic: $2.04. Optimistic: $2.34
Affimed N.V. (AFMD) Monthly Stock Prediction for 2026
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jan | 2.29 | 2.14 | 2.48 | 13.63 |
Feb | 2.15 | 2.00 | 2.36 | 15.44 |
Mar | 2.16 | 1.98 | 2.32 | 14.82 |
Apr | 2.34 | 2.25 | 2.41 | 6.41 |
May | 2.46 | 2.36 | 2.57 | 7.82 |
Jun | 2.52 | 2.43 | 2.71 | 10.30 |
Jul | 2.60 | 2.41 | 2.68 | 10.00 |
Aug | 2.48 | 2.33 | 2.59 | 10.02 |
Sep | 2.32 | 2.14 | 2.51 | 14.79 |
Oct | 2.22 | 2.10 | 2.40 | 12.57 |
Nov | 2.28 | 2.17 | 2.46 | 11.56 |
Dec | 2.15 | 1.97 | 2.21 | 10.53 |
Affimed N.V. (AFMD) Monthly Stock Prediction for 2027
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jan | 2.33 | 2.19 | 2.41 | 9.16 |
Feb | 2.52 | 2.39 | 2.69 | 10.94 |
Mar | 2.41 | 2.30 | 2.47 | 6.91 |
Apr | 2.22 | 2.04 | 2.30 | 11.45 |
May | 1.97 | 1.79 | 2.05 | 12.55 |
Jun | 2.02 | 1.89 | 2.19 | 13.67 |
Jul | 2.00 | 1.82 | 2.09 | 12.75 |
Aug | 2.23 | 2.13 | 2.39 | 11.07 |
Sep | 2.32 | 2.18 | 2.50 | 12.51 |
Oct | 2.36 | 2.15 | 2.54 | 15.27 |
Nov | 2.31 | 2.11 | 2.45 | 13.78 |
Dec | 2.19 | 2.09 | 2.37 | 12.08 |
Affimed N.V. information and performance
IM NEUENHEIMER FELD 582, 69120, HEIDELBERG, DE
Market capitalization of the Affimed N.V. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of AFMD shares in the company outstanding by the market price of one share.
EBITDA of Affimed N.V. is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.